The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed...
The Advanced Manufacturing National Program Office held its annual Manufacturing USA Network Meeting on May 25 in Washington, DC. There were over 100 participants with representatives from each of the institutes and funding agencies attending nine unique sessions throughout the day.
Dr. Monica Gorman, Special Assistant to the President for...
The National Institute of Standards and Technology (NIST) has issued a Notice of Funding Opportunity for Manufacturing USA Workforce, Education and Vibrant Ecosystems (WEAVE) public serve awards to the 17 Manufacturing USA institutes for proposals in the following topic areas:
Partnerships amongst two or more institutes to build vibrant and...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project activities through the Institute’s Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro potency assays for vaccines being produced by mRNA and/or viral...
The NIIMBL eXperience is an exclusive in-person, all expenses paid immersion program that offers you real-world insight into biopharmaceutical industry careers through hands-on activities and direct interactions with industry professionals. The program targets African American/Black, Latinx, and Native...
